CN102688414B - 配合血液透析治疗尿毒症的中药组合物、制备方法及应用 - Google Patents
配合血液透析治疗尿毒症的中药组合物、制备方法及应用 Download PDFInfo
- Publication number
- CN102688414B CN102688414B CN 201210210548 CN201210210548A CN102688414B CN 102688414 B CN102688414 B CN 102688414B CN 201210210548 CN201210210548 CN 201210210548 CN 201210210548 A CN201210210548 A CN 201210210548A CN 102688414 B CN102688414 B CN 102688414B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- radix
- ethanol
- obtains
- quality
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 105
- 239000003814 drug Substances 0.000 title claims abstract description 99
- 208000037157 Azotemia Diseases 0.000 title claims abstract description 27
- 208000009852 uremia Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims description 20
- 238000011282 treatment Methods 0.000 claims abstract description 40
- 210000000582 semen Anatomy 0.000 claims abstract description 28
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 20
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 298
- 238000010828 elution Methods 0.000 claims description 49
- 239000007788 liquid Substances 0.000 claims description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- 239000000843 powder Substances 0.000 claims description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- 239000003480 eluent Substances 0.000 claims description 33
- 238000001631 haemodialysis Methods 0.000 claims description 31
- 230000000322 hemodialysis Effects 0.000 claims description 31
- 239000011347 resin Substances 0.000 claims description 21
- 229920005989 resin Polymers 0.000 claims description 21
- 241000756943 Codonopsis Species 0.000 claims description 20
- 241000628997 Flos Species 0.000 claims description 19
- 239000009636 Huang Qi Substances 0.000 claims description 18
- 238000001035 drying Methods 0.000 claims description 17
- 238000001179 sorption measurement Methods 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 14
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 14
- 230000001105 regulatory effect Effects 0.000 claims description 13
- 239000006071 cream Substances 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 11
- 229920006122 polyamide resin Polymers 0.000 claims description 11
- 238000011084 recovery Methods 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- 238000009495 sugar coating Methods 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 238000009501 film coating Methods 0.000 claims description 8
- 239000000314 lubricant Substances 0.000 claims description 8
- 239000005720 sucrose Substances 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 239000007888 film coating Substances 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 6
- 235000010234 sodium benzoate Nutrition 0.000 claims description 6
- 239000004299 sodium benzoate Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 39
- 208000003251 Pruritus Diseases 0.000 abstract description 36
- 208000002720 Malnutrition Diseases 0.000 abstract description 8
- 230000001071 malnutrition Effects 0.000 abstract description 8
- 235000000824 malnutrition Nutrition 0.000 abstract description 8
- 208000015380 nutritional deficiency disease Diseases 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 4
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 239000010282 Emodin Substances 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 240000007643 Phytolacca americana Species 0.000 abstract 1
- 235000009074 Phytolacca americana Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 241000222355 Trametes versicolor Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 abstract 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 39
- 210000004369 blood Anatomy 0.000 description 38
- 210000000952 spleen Anatomy 0.000 description 32
- 210000003491 skin Anatomy 0.000 description 28
- 210000003734 kidney Anatomy 0.000 description 19
- 230000007812 deficiency Effects 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 17
- 208000002193 Pain Diseases 0.000 description 16
- 235000009508 confectionery Nutrition 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 13
- 206010030113 Oedema Diseases 0.000 description 11
- 230000007803 itching Effects 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 239000003172 expectorant agent Substances 0.000 description 10
- 230000003419 expectorant effect Effects 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 238000000502 dialysis Methods 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 108090000445 Parathyroid hormone Proteins 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 102100036893 Parathyroid hormone Human genes 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 239000011800 void material Substances 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical group [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027336 Menstruation delayed Diseases 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- 208000029088 Phosphorus metabolism disease Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 102000007584 Prealbumin Human genes 0.000 description 2
- 108010071690 Prealbumin Proteins 0.000 description 2
- 208000008425 Protein deficiency Diseases 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 102000002070 Transferrins Human genes 0.000 description 2
- 108010015865 Transferrins Proteins 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 206010048222 Xerosis Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 208000022458 calcium metabolism disease Diseases 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229960003943 hypromellose Drugs 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N methylguanidine Chemical compound CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000003393 splenic effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 239000002441 uremic toxin Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010061666 Autonomic neuropathy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000222356 Coriolus Species 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010067557 Dysmetropsia Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021750 Infantile Spasms Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- VVHOUVWJCQOYGG-REOHCLBHSA-N N-amidino-L-aspartic acid Chemical compound NC(=N)N[C@H](C(O)=O)CC(O)=O VVHOUVWJCQOYGG-REOHCLBHSA-N 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 206010034240 Pelvic congestion Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005770 Secondary Hyperparathyroidism Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000035286 Spontaneous Remission Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 208000013257 developmental and epileptic encephalopathy Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- -1 flesh liver Chemical compound 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 102000005396 glutamine synthetase Human genes 0.000 description 1
- 108020002326 glutamine synthetase Proteins 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000013007 heat curing Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 201000005991 hyperphosphatemia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940082629 iron antianemic preparations Drugs 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000002694 phosphate binding agent Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 210000003859 smegma Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 治疗前 | 治疗后 | 清除率(%) |
治疗组 | 294.9+235.5 | 134.1+103.4 | 48.5+55.1 |
对照组 | 295.7+213.4 | 251.3+95.6 | 13.2+30.3 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210210548 CN102688414B (zh) | 2012-06-25 | 2012-06-25 | 配合血液透析治疗尿毒症的中药组合物、制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210210548 CN102688414B (zh) | 2012-06-25 | 2012-06-25 | 配合血液透析治疗尿毒症的中药组合物、制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102688414A CN102688414A (zh) | 2012-09-26 |
CN102688414B true CN102688414B (zh) | 2013-10-30 |
Family
ID=46854258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210210548 Expired - Fee Related CN102688414B (zh) | 2012-06-25 | 2012-06-25 | 配合血液透析治疗尿毒症的中药组合物、制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102688414B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103205704A (zh) * | 2012-01-16 | 2013-07-17 | 昆山允升吉光电科技有限公司 | 蒸镀用掩模板 |
CN103285183B (zh) * | 2013-06-25 | 2014-07-23 | 莫少忠 | 一种治疗尿毒症的中药 |
CN103520407B (zh) * | 2013-09-23 | 2015-04-15 | 刘艳艳 | 一种用于治疗肾透析并发症的中药制剂及制备方法 |
CN103933163B (zh) * | 2014-03-26 | 2016-01-20 | 刘凌 | 一种治疗血液透析后皮肤瘙痒症的中药洗浴剂 |
CN104147199B (zh) * | 2014-08-29 | 2016-03-09 | 淄博夸克医药技术有限公司 | 一种用于治疗尿毒症的中药 |
CN104644976A (zh) * | 2015-02-10 | 2015-05-27 | 青岛市市立医院 | 一种配合血液透析治疗尿毒症的中药配方 |
CN104740611B (zh) * | 2015-04-13 | 2017-04-12 | 江西康宝医药生物科技有限公司 | 一种治疗尿毒症的中药组合物及其制备方法 |
CN104984056A (zh) * | 2015-06-05 | 2015-10-21 | 刘源 | 一种治疗尿毒症患者皮肤瘙痒的中药外洗剂 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085251A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 治疗肾病综合征的一种中药制剂 |
CN101085266A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 治疗尿毒症的一种中药制剂 |
CN101085323A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 治疗尿毒症的中药组合 |
CN101085159A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 一种治疗肾病综合征的中药组合 |
-
2012
- 2012-06-25 CN CN 201210210548 patent/CN102688414B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085251A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 治疗肾病综合征的一种中药制剂 |
CN101085266A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 治疗尿毒症的一种中药制剂 |
CN101085323A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 治疗尿毒症的中药组合 |
CN101085159A (zh) * | 2007-06-26 | 2007-12-12 | 北京艺信堂医药研究所 | 一种治疗肾病综合征的中药组合 |
Non-Patent Citations (8)
Title |
---|
中药透析疗法在肾脏疾病中的应用;周昌娥;《护理研究》;20060211;第20卷(第2期);第388-390页 * |
刘宏伟.尿毒症皮肤瘙痒症有何特征?如何治疗?.《中医杂志》.1996,第37卷(第5期),第311页. |
周昌娥.中药透析疗法在肾脏疾病中的应用.《护理研究》.2006,第20卷(第2期),388-390页. |
周清发.瓦松煎水外洗治疗肾性皮肤瘙痒.《中国皮肤性病学杂志》.1994,第8卷(第4期),262页. |
尿毒症皮肤瘙痒症有何特征?如何治疗?;刘宏伟;《中医杂志》;19960515;第37卷(第5期);第311页3-6段 * |
慢性肾衰性皮肤瘙痒的中医治疗探讨;王琦和王灿辉;《南京中医药大学学报》;19980501;第14卷(第3期);第170页3-6段 * |
王琦和王灿辉.慢性肾衰性皮肤瘙痒的中医治疗探讨.《南京中医药大学学报》.1998,第14卷(第3期),170页. |
瓦松煎水外洗治疗肾性皮肤瘙痒;周清发;《中国皮肤性病学杂志》;19941115;第8卷(第4期);第262页 * |
Also Published As
Publication number | Publication date |
---|---|
CN102688414A (zh) | 2012-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102688414B (zh) | 配合血液透析治疗尿毒症的中药组合物、制备方法及应用 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN101607051B (zh) | 一种中药减肥组合物及其制备方法 | |
CN103432559A (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN106177786A (zh) | 一种治疗艾滋病的中药组合物及其制备方法 | |
CN104042971A (zh) | 用于治疗阴虚毒热型肺癌的药物组合物及其制备方法 | |
CN106266999A (zh) | 一种治疗心神不安及心悸失眠的中药组合物及其制备方法 | |
CN103041307A (zh) | 用于治疗慢性溃疡性结肠炎的中药组合物及其制备方法 | |
CN103191331B (zh) | 用于治疗支气管哮喘缓解期的中药组合物 | |
CN105213807A (zh) | 用于治疗阴虚火旺型复发性口腔溃疡的药物 | |
CN101897933A (zh) | 一种治疗白癜风的中成药 | |
CN103191399A (zh) | 用于治疗支气管哮喘急性发作期的中药组合物 | |
CN105535787A (zh) | 一种用于治疗结节性甲状腺肿的药物制剂及其用途 | |
CN102552767B (zh) | 治疗肾结石的中药、制备方法及给药方式 | |
CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
CN104758466A (zh) | 治疗急性胆囊炎的中药制剂及制法 | |
CN1327874C (zh) | 治疗慢性前列腺炎的中药制剂及其制备方法 | |
CN104840864B (zh) | 一种治疗小儿脾虚型腹泻的中药制剂 | |
CN104225498A (zh) | 用于治疗原发性寒湿凝滞型痛经的药物组合物及其制备方法 | |
CN104491364B (zh) | 一种治疗慢性淋巴细胞性甲状腺炎的药丸及制备方法 | |
CN102716341B (zh) | 治疗急性消化性溃疡出血的中药组合物及其制备方法 | |
CN103041194A (zh) | 用于治疗慢性湿疹的中药组合物及其制备方法 | |
CN102784307A (zh) | 一种用于治疗肺结核的中药及制备方法 | |
CN105381410A (zh) | 一种治疗肝炎的中药制剂 | |
CN106310019A (zh) | 一种治疗肺痿的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. Free format text: FORMER OWNER: XU MEI Effective date: 20130927 |
|
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Dong Fang Inventor after: Wan Xichao Inventor after: Xu Mei Inventor before: Xu Mei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: XU MEI TO: DONG FANG WAN XICHAO XU MEI Free format text: CORRECT: ADDRESS; FROM: 237200 LU'AN, ANHUI PROVINCE TO: 266071 QINGDAO, SHANDONG PROVINCE |
|
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130927 Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Applicant after: Qingdao Huaren Technology Incubator Co., Ltd. Address before: 237200 Anhui city in Lu'an Province, but the streets of Mount Holyoke County Shilin equipment company Jia Miao Zhen Hospital Applicant before: Xu Mei |
|
ASS | Succession or assignment of patent right |
Owner name: QIAN XIUYING Free format text: FORMER OWNER: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. Effective date: 20141212 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266071 QINGDAO, SHANDONG PROVINCE TO: 213000 CHANGZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141212 Address after: 213000 Jiangsu city of Changzhou province Kelelu New District No. 1 Srif textile machinery integrated plant 5 Patentee after: Qian Xiuying Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Patentee before: Qingdao Huaren Technology Incubator Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: RUGAO JIANGBEI ADDITIVE CO., LTD. Free format text: FORMER OWNER: QIAN XIUYING Effective date: 20150120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 213000 CHANGZHOU, JIANGSU PROVINCE TO: 226500 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150120 Address after: 226500 No. 9 Wangjiang Road, Changjiang town (Rugao port), Jiangsu, Rugao Patentee after: Rugao Jiangbei Additive Co., Ltd. Address before: 213000 Jiangsu city of Changzhou province Kelelu New District No. 1 Srif textile machinery integrated plant 5 Patentee before: Qian Xiuying |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131030 Termination date: 20160625 |